Overview

Self-Selection and Actual Use Trial of Ibuprofen 600 mg Immediate Release/Extended Caplet

Status:
Completed
Trial end date:
2013-06-03
Target enrollment:
Participant gender:
Summary
A self-selection and actual use trial to evaluate the extent to which consumers will appropriately select and use the 600 mg immediate release/extended release caplets and comply with dosing instructions.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Ibuprofen